$BWB

BWB Q3'26 Earnings: revenue estimate is 43.20M USD

Bridgewater Bancshares (BWB) plans to release Q3'26 earnings on October 20. Analysts expect revenue of 43.20M USD and EPS of 0.47 USD. Results will be announced after market close.

Original reporting
Published Oct 13, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 11:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BWB Q3'26 Earnings: revenue estimate is 43.20M USD — source image
Decision brief

The 30-second read

$BWBNeutralLow
01

Why it matters

The earnings preview provides the first public guidance for Q3'26, offering a trading hook for short‑term positioning.

02

Market read

The article supplies new earnings guidance for a micro‑cap bank, offering limited but actionable insight for pre‑earnings traders.

03

What to watch

Potential hidden cost controls or loan portfolio changes not reflected in the headline estimate.

Relevance 5/10Novelty 6/10Timing: pre‑earnings on Oct 20

Background

Bridgewater Bancshares is a community‑focused bank with a market cap under $200M, regularly reporting modest earnings.

Company-level read

Ticker impact

$BWBNeutralMedium confidence
Context

Bridgewater Bancshares (BWB) will release its Q3'26 earnings on Oct 20 with revenue estimate of $43.2M and EPS $0.47.

Expected impact

potential pressure if results fall short of the $43.2M revenue estimate; upside if beat.

Evidence & confidence

Micro‑cap earnings with low absolute numbers usually generate limited but directional moves around the release.

Market effects

Minimal impact on regional banking sector; serves as a data point for small‑cap bank performance.

Limited to U.S. small‑cap banking niche.

Low

Counterpoint

Even modest guidance could be a catalyst if investors have been overly bearish on BWB.

Key entities

  • Bridgewater Bancshares, Inc.

    U.S. regional bank (ticker BWB) reporting Q3'26 earnings.

Related articles

$BWBMed

Bridgewater Bancshares, Inc. Announces Second Quarter 2026 Financial Results

Bridgewater Bancshares Inc (BWB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bwb-20260721xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ Media Contact: Emily Karpenske | Senior Communication Specialist Emily.Karpenske@bwbmn.com | 952.653.0624 Investor Contact: Justin Horstman | VP Investor Relations Justin.Horstman@bwbmn.com | 952.542.5169 ​ July 21, 202

$UNHMedAI 8/10

UnitedHealth Group stock trims gains on profit outlook increase

UnitedHealth Group (UNH) raised its full-year profit forecast to at least $20.50 per share, up from $19.50-$20, after Q3 earnings beat estimates. The stock initially jumped 5% but trimmed gains. The company is executing a turnaround plan. Year-to-date, the stock is up 14%. Berkshire Hathaway previously sold its stake in UNH.

$GSMedAI 9/10

[The Goldman Sachs Group Q3 2026 Earnings Call] Goldman Posts Second-Best Quarter Ever With $18.7B Revenue, 72% Equities Surge as Asia Bet Pays Off

Goldman Sachs reported Q3 2026 net revenues of $18.7B, its second-highest ever, driven by a 72% surge in equities revenues and record investment banking advisory fees. CEO David Solomon highlighted strong performance with EPS of $17.01, ROE of 18.7%, and ROTE of 20.5%. Asia's share of firm-wide revenues increased, reflecting strategic investments. Investment banking advisory revenues hit a quarterly record of $1.7B, while Asset & Wealth Management revenues rose 14% to $5.1B.

$UNHHighAI 9/10

UnitedHealth Stock Surges as Wall Street Gets Major Surprise

UnitedHealth Group (UNH) shares rose 4% premarket after beating Q3 earnings estimates and raising its 2026 adjusted EPS outlook to $20.50, up from $19.50-$20. Q3 revenue was $112.7B, down 0.4% YoY but $1.21B above estimates. The medical care ratio improved to 88.4% from 89.9% due to cost initiatives and favorable reserve development. Optum Health revenue declined 10% YoY. Peers like Humana and CVS Health also saw share increases.